PEAK6 Investments’s Usana Health Sciences USNA Stock Holding History

PEAK6 Investments’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-915	Closed	-$53K	–	4861
2020 Q1	$53K	Buy	+915	New	+$63.6K	﹤0.01%	3575
2019 Q3	–	Sell	-119	Closed	-$9K	–	4329
2019 Q2	$9K	Buy	+119	New	+$9.44K	﹤0.01%	3497

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PEAK6 Investments's USNA Position: Q2 2020 in Review

PEAK6 Investments sold out of Usana Health Sciences (USNA) in Q2 2020, closing a stake of 915 shares — an estimated $53K sold.

PEAK6 Investments first reported a position in USNA in Q2 2019 and held it in 2 quarters. The position peaked at $53K in Q1 2020. 192 funds tracked by Wall St. Rank hold USNA as of Q2 2020.

PEAK6 Investments reported no remaining Usana Health Sciences position as of Q2 2020 after selling out during the quarter.
PEAK6 Investments sold 915 Usana Health Sciences shares in Q2 2020, an estimated $53K.
PEAK6 Investments first reported a position in Usana Health Sciences in Q2 2019 and held it in 2 quarters.
PEAK6 Investments's Usana Health Sciences position peaked at $53K in Q1 2020.
192 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2020.

Based on PEAK6 Investments's 13F filing for Q2 2020, filed 14 Aug 2020.